New bone cutting technology from Finnish startup Surgify that prevents severe complications gets first surgical use
Finnish startup Surgify that recently launched an all-new and innovative surgical technology which allows surgeons to perform surgical operations on bones faster and safer has seen its first use cases on patients.
Surgify’s flagship cutting technology is a result of diligent development work. The first surgeries were successfully performed in October 2021 at Helsinki University Hospital (HUS), and the results are extremely promising.
“The two surgical patients recovered well from their surgeries and returned home quickly. Neither faced soft tissue damage during the operation,” says Head of HUS Neurosurgery and Professor Mika Niemelä.
Surgify’s technology cuts bone while preventing injuries to easily damageable soft tissues such as meninges, muscles, blood vessels, nerve pathways, or central nervous system structures. Depending on the type of surgery, the risk of soft tissue damage can be up to 30 percent. With Surgify’s technology, such injuries can possibly be avoided entirely. Severe soft tissue damage can, at worst, result in permanent injury or patient death.
“Surgify’s device appears to push the soft tissue out of the way. This is a major advantage, as a typical surgical drill that spins tens of thousands of times in a minute can be very dangerous if it touches soft tissue,” adds Niemelä.
Clinical procedures with Surgify’s new technology will continue at HUS.
Innovation that results in millions in savings for hospitals and paves the way for the use of robotics
Surgify’s technology can potentially save hospitals up to €3 million a year, thanks to the prevention of complications and lessened need for continued care. When the soft tissue is not damaged, the patient needs less treatment, recovers faster, and postoperative complications are less likely.
Soft tissue damage is particularly common in the elderly, as the tissue in older patients is naturally more fragile. As the number of elderly patients increases, so do the risks. Globally, such complications cost nearly €4 billion, and as the population ages, this can be expected to grow without innovative solutions.
New technological devices are making a breakthrough in medical care. Already today, robots are used to operate some parts of the surgery. Surgify’s technology is perfectly suitable for both traditional handheld surgeries as well as surgical robotics.
“We see our solution as part of a bigger change that is happening in surgery, and that enables wider use of automation in many types of procedures. We envision enabling surgeons to perform their surgical skills beyond the limitations of current surgical instrumentation, allowing best-in-class surgical procedures for every patient and cost-efficient innovation for the health system,” says Surgify’s CEO, Visa Sippola.
Next, Surgify targets the international market with its product. Their internationalization strategy is sharpened by their newly appointed Chair of Board, Lex R. Giltaij MD MBA. He has been serving for more than 30 years in senior executive positions creating and building international businesses for many orthopedic and spinal companies, amongst them Stryker, St. Francis Medical Technology (now Medtronic), and Pioneer Surgical (now RTI Surgical).
“We’re starting in the Nordic countries and will soon take our groundbreaking technology to the international markets in the EU and USA. We are also looking forward to continuing our effective collaboration work with HUS,” Giltaij concludes.
For additional information
CEO, Surgify Medical
+358 50 353 1232
Surgify Medical is a Finnish health technology startup company founded in 2017 with the goal of making bone surgery safer. The company is commercializing its next-generation surgical bone cutting technology and is targeting international markets.
The technology was originally developed in collaboration between Aalto University and Helsinki University Hospital (HUS) Department of Neurosurgery. Surgify’s product is a new type of cutting device with a patented safety mechanism that pushes soft tissue away and prevents the drill from damaging vital structures such as nerves or blood vessels.
Since its inception, Surgify has raised € 4.7 million in private and public funding and has received an innovation award from MIT Technology Review. The company has received some of its public funding from Business Finland. For more information, visit www.surgifymedical.com.
Congrats to all of the promising young visionaries! Let’s change the world together.
As seen in Helsingin Sanomat: https://www.hs.fi/visio/art-2000007826386.html
Finnish startup Surgify Medical Oy raises €1.4 million and is looking for international breakthrough with safer surgical technology
Surgify Medical Oy, a Finnish company that develops safer surgical technology, has raised €1.4 million in funding from both domestic and foreign investors.
ESPOO, Finland (January 8th, 2021, 9 AM GMT) In addition to existing backers, among the investors in the startup’s third round were Finnish venture capital investor Innovestor Ventures, Swedish investor Peter Lindell, and well-known Finnish angel investor and healthcare entrepreneur Leena Niemistö. The funding will be used to bring Surgify’s safer surgical drill to market.
Surgify’s internationally recognised technology is intended to prevent nerve and blood vessel injuries caused by surgical drills. The company believes that their technology plays an important role in saving lives and making bone surgery safer. Furthermore, the time and money spent on surgeries could be decreased considerably. In addition to performing various surgical procedures in the head, neck, and spine areas, the technology can be used in dental procedures, as well as surgical robotics.
”The technology developed and patented by us has worked excellently in pre-clinical trials, and has prevented practically all relevant complications. We have raised the interest of leading hospitals in both Europe and the US, and the industry’s largest players have also expressed their interest in collaborating,” said the company’s CEO, Visa Sippola.
Surgify aims to reshape how surgery is performed
Surgify received a sales approval for its product in May, and since then has focused on developing its production. Potential factors contributing to the adoption of the technology in hospitals include ease of use, as well as expected reductions in surgical costs and complications.
The company’s investors see significant challenges brought about by an ageing population, prompting a growth in the number of surgical patients. Today, global costs resulting from complications with surgical drills total over €4 billion annually.
”Surgify’s technology contributes to solving major public health issues, and enables fundamental changes in the surgical market. Innovestor decided to invest in Surgify because of its promising technology and founding team, and because its mission genuinely adds value to society”, commented Innovestor Group’s partner and head of investments, Wilhelm Lindholm.
The rapidly growing startup has spent a significant amount of effort on product development and trials with numerous surgeons. The company is now bringing its technology to the market, aiming for first hospital customers in Finland and the Nordics next year, and expanding to international markets after this.
”This third investment round is an important milestone for Surgify, and, combined with the market approval and patents, positions the company well for market entry. Despite long development cycles in the medical industry, we believe that our work will pay off and that we have a good foundation for building a global business”, Sippola celebrates.
- Nordic9: https://nordic9.com/news/surgify-to-raise-1-4-million-from-innovestor-ventures-and-angel-investors-peter-lindell-and-leena-ni-news2219403700/
- Silicon Canals: https://siliconcanals.com/news/startups/finland-startup-surgify-medical-funding/
- Tech.eu: https://tech.eu/brief/surgify-funding/
- Talouselämä: https://www.talouselama.fi/uutiset/aivoporaa-kehittava-startup-kerasi-miljoonarahoituksen-sijoittajana-myos-dextra-miljonaari-leena-niemisto/c57f536d-51e4-484e-a375-0826a7eef8fb
- FVCA: https://paaomasijoittajat.fi/en/innovestor-invests-in-surgify-medical-reshaping-how-surgery-is-performed/
- Spark Finland: https://sparkfinland.fi/surgify-medical-raised-14-million-euro-private-funding/
- Kauppalehti: https://www.kauppalehti.fi/uutiset/aivoporaa-kehittava-startup-kerasi-1-4-miljoonan-euron-rahoituksen-sijoittajana-myos-dextra-miljonaari-leena-niemisto/75e8ff78-2da0-4d65-b146-8a82b792d174
- Good News from Finland: https://www.goodnewsfinland.com/daily-brief-icebreakers-startup-coin-workforce-development-acquisition-and-travel/
CEO, Surgify Medical
+358 50 353 1232
Surgify Medical Oy is a Finnish healthcare technology startup, founded in 2017. The company is developing an internationally recognised surgical drill that aims to make bone surgery safer.
The technology was originally developed in a collaboration between Aalto University and the Helsinki University Hospital Department of Neurosurgery. The product is a safety tip that is connected to existing surgical drills. The patented safety mechanism prevents the drill from damaging important soft tissues, such as nerves and blood vessels.
Visa Sippola shares some of his thoughts about Surgify in Liituraitalenkkarit podcast.
Liituraitalenkkarit podcast is available in Finnish at:
- Spotify: https://open.spotify.com/show/6EbHHB5OS9s8Fgau0lYcty
- Soundcloud: https://soundcloud.com/toni-hannukainen/liituraitalenkkarit-podcast-3-vieraana-visa-sippola
Visa Sippola Was Chosen as one of the Young Influencers of the Future 2019 by Yle Kioski. The jury appreciated for example Visa’s courage and ability to build a multidisciplinary team around his vision of safer bone surgery.
You can read the full article in Finnish at: https://yle.fi/aihe/artikkeli/2019/11/09/yle-kioski-valitsi-tulevaisuuden-vaikuttajat-2019
Our early investor Wave Ventures sat down with Visa Sippola, the CEO and co-founder of Surgify to discuss the company’s journey, future plans and the field of MedTech in general.
You can listen to the full Wavecast interview at:
- YouTube: https://youtu.be/cKJjuoasJWI
- Spotify: https://open.spotify.com/episode/3jBGz7genK5ecvjLWo5N2h
- Soundcloud: https://soundcloud.com/wave-ventures/medtech-with-surgify-wavecast
If you want to learn more about Wave Ventures, read more at wave.ventures.
We’re hiring a Junior Product Development Engineer (Apply by July 10th 2019, edit: application period has been closed)
EDIT: Thank you for all of the applicants! We have found a talented engineer to join our team.
Guess what?! We’re looking for a talented Junior Product Development Engineer to join our great team in Otaniemi! Apply here by July 10th! Great opportunity to join on our mission to make bone surgery safer!
Further information: aTalent Recruiting – Junior Product Development Engineer (healthtech) (EDIT: the application has been closed)
Surgify’s CEO Visa Sippola shares the story of Surgify in an interview with City of Helsinki. Read more at Helsinki – A surgical innovation set to conquer operating rooms all over the world.
Visa Sippola shares insights on the cooperation between Surgify, Aalto University and Helsinki University in an interview made by Aalto University. Read more at Surgify aims to make bone surgery safer around the world.
Last week, the European Venture Contest connected European startups and venture capitalists in Düsseldorf, Germany for the 12th time. In a competition of over 2 400 startup companies, Finnish companies Surgify and LullaMe were chosen as winners of their own categories.
”This is excellent for our Finnish companies! There are surprisingly many startups in Finland that are interesting to venture capitalists” tells Visa Sippola, CEO of Surgify.
Over 2 400 startups from 27 countries applied to the European Venture Contest. 600 interesting companies made it to the regional semifinals and 125 best companies were invited to the final in Düsseldorf. In the final, a jury, consisting of venture capital investors, chose the winners for each of the 24 categories of the competition.
Surgify and LullaMe were two of these jury favorites based on an assessment of an online application and a live pitch presentation in Düsseldorf.
Surgify develops surgical drill technology which cuts bone selectively and protects the vital soft structures of the patients. LullaMe sells and produces innovative rocking mattresses that help babies to sleep.
”According to professional investors, we are now among the most interesting 1 percent of European growth companies. This gives us the best possible kick for the international growth”, says Hanna Sissala, CEO & Founder of LullaMe.
Read more at: